Search results

Found 150 pages
AUTHOR: PharmaTimes Reporter

Results per page

10 20 50 100

Sort by

Relevance Date

16 Mar 2015:

UK life sciences financing on the up

There has been a resurgence in life sciences financing in the UK, amounting to $2.86 billion, new figures reveal.  - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/uk_life_sciences_financing_on_the_up_971188

16 May 2017:

ReNeuron wins £1.8 million for cell therapy development

Innovate UK grant will help advance its manufacturing capabilities - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/reneuron_wins_1.8_million_for_cell_therapy_development_1192904

12 May 2017:

Pfizer strikes gene therapy deal with Sangamo

Says one of the candidates included has best-in-class potential - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/pfizer_strikes_gene_therapy_deal_with_sangamo_1192766

15 May 2017:

Takeda establishes new drug discovery subsidiary

Also transfers part of its pharmaceutical sciences businesses to Bushu - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/takeda_establishes_new_drug_discovery_subsidiary_1192847

18 May 2017:

Video surveillance could support dementia patients

But consent would be key for the use of home camera-based systems - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/video_surveillance_could_support_dementia_patients_1193020

22 Aug 2013:

Risk specialists arrested in China

A husband and wife corporate investigation team that have reportedly worked for GlaxoSmithKline have been arrested in China. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/risk_specialists_arrested_in_china_1005582

16 May 2017:

NHS could save £67 million a year if smoking rates cut

But would need rates to drop to 5 percent - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/nhs_could_save_67_million_a_year_if_smoking_rates_cut_1192906

12 Aug 2013:

Teva gets EU nod for Neulasta 'biobetter'

Teva has chalked up a milestone in its branded products business after winning EU approval for Lonquex, a white blood cell stimulator that will compete with Amgen's blockbuster Neulasta brand. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/teva_gets_eu_nod_for_neulasta_biobetter_1005530

28 May 2015:

Gilead-backed Hep B vaccine fails

GlobeImmune and partner Gilead suffered a setback this week after its new hepatitis B vaccine GS-4774 missed its mid-stage trial target. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/gilead-backed_hep_b_vaccine_fails_971449

29 May 2015:

FDA approves Salix and Actavis IBS drugs

Two new treatments for irritable bowel syndrome (IBS) have been approved by the US Food and Drug Administration. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/fda_approves_salix_and_actavis_ibs_drugs_971451